SS Innovations International (SSII) Share-based Compensation (IS) (2023 - 2024)

SS Innovations International's (SSII) quarterly Share-based Compensation (IS) came in at $5.2 million in Q1 2024, up 224.78% year-on-year from $1.6 million in Q2 2023, and down 46.63% quarter-over-quarter from $9.7 million in Q4 2023.

SS Innovations International (SSII) Share-based Compensation (IS) (2023 - 2024) Analysis & Trends

SS Innovations International has disclosed Share-based Compensation (IS) across 2 years of filings, most recently posting $5.2 million for Q1 2024.

  • Share-based Compensation (IS) for Q1 2024 came in at $5.2 million, up 224.78% year-over-year; the trailing twelve-month figure through Mar 2024 was $14.9 million (changed N/A YoY), and the FY2023 annual result was $9.7 million, up 756.34% from the prior year.
  • Share-based Compensation (IS) came in at $5.2 million for Q1 2024 at SS Innovations International, down from $9.7 million in the prior quarter.
  • In the past five years, Share-based Compensation (IS) ranged from a high of $9.7 million in Q4 2023 to a low of $8150.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (IS) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 SS Innovations International 689.95 Mn 666.34 Mn 5.33 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2024 5.17 Mn
Mar 31, 2024 5.17 Mn
Dec 31, 2023 9.69 Mn
Dec 31, 2023 9.69 Mn
Sep 30, 2023 24,450.00
Sep 30, 2023 24,450.00
Jun 30, 2023 8,150.00
Jun 30, 2023 8,150.00
Mar 31, 2023 1.59 Mn
Mar 31, 2023 1.59 Mn